AI Science Tracker
EN

Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer.

Department of Pharmacy · 30 Jun 2023 · medicine

Discovery

Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Swedish discovery plasma cohort and an independent UK validation cohort are compared; MMP12 is associated with shorter overall survival after adjustment.

Technology: Random-survival-forest analysis identifies plasma MMP12 as a prognostic marker in urothelial bladder cancer; targeted proteomics and macrophage analyses connect the signal to a cellular source.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Random-survival-forest analysis identifies plasma MMP12 as a prognostic marker in urothelial bladder cancer; targeted proteomics and macrophage analyses connect the signal to a cellular source.
Limitation / still unknown
Observational association does not establish causality or therapeutic value.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/article/MED/37391708 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC10311740/unicode · https://pubmed.ncbi.nlm.nih.gov/37391708/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.